Peak Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.38M | Sell |
4,755
-69
| -1% | -$33.1K | 0.35% | 53 |
|
|
2026
Q1 | $2.37M | Buy |
4,824
+134
| +3% | +$72.7K | 0.42% | 50 |
|
|
2025
Q4 | $2.72M | Buy |
4,690
+69
| +1% | +$39K | 0.46% | 42 |
|
|
2025
Q3 | $2.24M | Sell |
4,621
-85
| -2% | -$39.6K | 0.39% | 50 |
|
|
2025
Q2 | $1.91M | Buy |
4,706
+1,280
| +37% | +$535K | 0.35% | 53 |
|
|
2025
Q1 | $1.7M | Buy |
3,426
+23
| +0.7% | +$12.5K | 0.32% | 56 |
|
|
2024
Q4 | $1.77M | Hold |
3,403
| – | – | 0.33% | 57 |
|
|
2024
Q3 | $2.1M | Buy |
3,403
+286
| +9% | +$169K | 0.4% | 50 |
|
|
2024
Q2 | $1.72M | Hold |
3,117
| – | – | 0.34% | 58 |
|
|
2024
Q1 | $1.81M | Sell |
3,117
-77
| -2% | -$43.2K | 0.36% | 60 |
|
|
2023
Q4 | $1.7M | Buy |
3,194
+114
| +4% | +$55.2K | 0.37% | 59 |
|
|
2023
Q3 | $1.56M | Buy |
3,080
+9
| +0.3% | +$4.8K | 0.38% | 62 |
|
|
2023
Q2 | $1.6M | Buy |
3,071
+105
| +4% | +$56.7K | 0.37% | 60 |
|
|
2023
Q1 | $1.71M | Buy |
2,966
+116
| +4% | +$65.4K | 0.42% | 56 |
|
|
2022
Q4 | $1.57M | Hold |
2,850
| – | – | 0.41% | 57 |
|
|
2022
Q3 | $1.45M | Sell |
2,850
-29
| -1% | -$16.2K | 0.41% | 53 |
|
|
2022
Q2 | $1.56M | Sell |
2,879
-3
| -0.1% | -$1.65K | 0.43% | 48 |
|
|
2022
Q1 | $1.7M | Sell |
2,882
-318
| -10% | -$183K | 0.4% | 50 |
|
|
2021
Q4 | $2.13M | Sell |
3,200
-58
| -2% | -$36.2K | 0.49% | 41 |
|
|
2021
Q3 | $1.86M | Sell |
3,258
-27
| -0.8% | -$14.8K | 0.46% | 43 |
|
|
2021
Q2 | $1.66M | Sell |
3,285
-25
| -0.8% | -$11.8K | 0.41% | 43 |
|
|
2021
Q1 | $1.51M | Sell |
3,310
-606
| -15% | -$289K | 0.37% | 49 |
|
|
2020
Q4 | $1.82M | Buy |
3,916
+3
| +0.1% | +$1.41K | 0.48% | 45 |
|
|
2020
Q3 | $1.73M | Sell |
3,913
-192
| -5% | -$79.3K | 0.52% | 43 |
|
|
2020
Q2 | $1.49M | Buy |
4,105
+111
| +3% | +$37.2K | 0.47% | 42 |
|
|
2020
Q1 | $1.13M | Buy |
3,994
+447
| +13% | +$141K | 0.44% | 44 |
|
|
2019
Q4 | $1.15M | Buy |
3,547
+14
| +0.4% | +$4.25K | 0.35% | 51 |
|
|
2019
Q3 | $1.03M | Buy |
3,533
+145
| +4% | +$41.5K | 0.34% | 51 |
|
|
2019
Q2 | $995K | Sell |
3,388
-444
| -12% | -$122K | 0.33% | 57 |
|
|
2019
Q1 | $1.05M | Sell |
3,832
-135
| -3% | -$33.6K | 0.36% | 56 |
|
|
2018
Q4 | $888K | Sell |
3,967
-60
| -1% | -$14.1K | 0.33% | 56 |
|
|
2018
Q3 | $983K | Sell |
4,027
-149
| -4% | -$34.3K | 0.33% | 56 |
|
|
2018
Q2 | $865K | Buy |
4,176
+408
| +11% | +$86.6K | 0.31% | 55 |
|
|
2018
Q1 | $778K | Sell |
3,768
-130
| -3% | -$27.3K | 0.29% | 59 |
|
|
2017
Q4 | $740K | Hold |
3,898
| – | – | 0.27% | 63 |
|
|
2017
Q3 | $738K | Buy |
3,898
+9
| +0.2% | +$1.63K | 0.26% | 72 |
|
|
2017
Q2 | $679K | Sell |
3,889
-176
| -4% | -$29.6K | 0.25% | 73 |
|
|
2017
Q1 | $624K | Sell |
4,065
-257
| -6% | -$39.3K | 0.24% | 75 |
|
|
2016
Q4 | $610K | Buy |
4,322
+123
| +3% | +$18.1K | 0.24% | 81 |
|
|
2016
Q3 | $668K | Sell |
4,199
-35
| -0.8% | -$5.39K | 0.28% | 72 |
|
|
2016
Q2 | $626K | Hold |
4,234
| – | – | 0.28% | 69 |
|
|
2016
Q1 | $599K | Buy |
4,234
+1,295
| +44% | +$174K | 0.28% | 66 |
|
|
2015
Q4 | $417K | Hold |
2,939
| – | – | 0.2% | 75 |
|
|
2015
Q3 | $359K | Hold |
2,939
| – | – | 0.19% | 76 |
|
|
2015
Q2 | $381K | Buy |
2,939
+44
| +2% | +$5.74K | 0.2% | 80 |
|
|
2015
Q1 | $389K | Hold |
2,895
| – | – | 0.19% | 81 |
|
|
2014
Q4 | $363K | Buy |
+2,895
| New | +$352K | 0.19% | 78 |
|
Other funds holding TMO
Peak Asset Management's TMO Position: Q2 2026 in Review
Peak Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 1.4% in Q2 2026, selling an estimated $33.1K and leaving 4,755 shares worth $2.38M. The position accounts for 0.35% of the portfolio, ranked #53.
Peak Asset Management first reported a position in TMO in Q4 2014 and has held it in 47 quarters since. The position peaked at $2.72M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Peak Asset Management held 4,755 shares of Thermo Fisher Scientific worth $2.38M as of Q2 2026.
- Peak Asset Management sold 69 Thermo Fisher Scientific shares in Q2 2026, an estimated $33.1K.
- Thermo Fisher Scientific made up 0.35% of Peak Asset Management's portfolio in Q2 2026, its #53 holding.
- Peak Asset Management first reported a position in Thermo Fisher Scientific in Q4 2014 and has held it in 47 quarters since.
- Peak Asset Management's Thermo Fisher Scientific position peaked at $2.72M in Q4 2025.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Peak Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.